Ontology highlight
ABSTRACT: Purpose
To evaluate the efficacy of initiating osteoporosis medication within 3 months after a fracture and continuing it for at least 6 months in preventing secondary fractures among individuals aged ≥ 75 years.Methods
This study used a targeted trial design, emulating a randomized controlled trial with Japanese administrative claims data from 2014-2022. Among 203,534 individuals with recent osteoporotic fractures, 40,063 initiated osteoporosis medication within 3 months (exposed), while 163,471 did not (controls). High-dimension
SUBMITTER: Tsukamoto M
PROVIDER: S-EPMC12628409 | biostudies-literature | 2025 Nov
REPOSITORIES: biostudies-literature